Treatment of patients with hepatic metastases

Cancer Journal

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Bartlett, David L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CATHETER ABLATION; COLORECTAL CANCER; CRYOTHERAPY; DIGESTIVE SYSTEM CANCER; HUMAN; LIVER METASTASIS; LIVER RESECTION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; CRYOTHERAPY; HUMANS; LIVER NEOPLASMS; TREATMENT OUTCOME;

EID: 0033913659     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. American Cancer Society. Cancer Statistics 1999. Can J Clin 1999;49:8-31.
2. Daly JM, Kemeny NE. Metastatic cancer to the liver. In: DeVita VT Jr., Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology (5th ed). Philadelphia: Lippincott-Raven, 1997:2551-2570.
3. Alexander HR, Bartlett DL, Fraker DL, Libutti SK. Regional treatment strategies for unresectable primary or metastatic cancer confined to the liver. In: DeVita VT Jr., Hellman S, Rosenberg SA, eds. PPO Updates Principles and Practice of Oncology. Philadelphia: Lippincott-Raven, 1996;10:1-19.
4. Billingsley K, Jarnagin WR, Fong Y, Blumgart LH. Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg 1998;187:471-481.
5. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
6. Fong Y et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
7. Harrison LE et al. Hepatic resection for noncolorectal, non-neuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 1997;121:625-632.
8. Jaques DP, Coit DG, Casper ES, Brennan MF. Hepatic metastases from soft-tissue sarcoma. Ann Surg 1995; 221:392-397.
9. Raab R, Nussbaum KT, Behrend M, Weimann A. Liver metastases of breast cancer: results of liver resection. Anticancer Res 1998;18:2231-2233.
10. Ochiai T, Sasako M, Mizuno S. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 1994;81:1175-1178.
11. Chen H et al. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998;187:88-92.
12. Que FG et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995;169:36-43.
13. Watanabe Y et al. Laparoscopic hepatic resection: A new and safe procedure by abdominal walllifting method. Hepatogastroenterology 1997;44:143-147.
14. Sugiura N et al. Percutaneous intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatologica Japan 1983;24: 920-923.
15. Amin Z, Bown SG, Lees WR. Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol 1993;48:166-171.
16. Ebara M, Ohto M, Sugiura N. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 1990;5:616-626.
17. Hasegawa S et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999;86:1682-1690.
18. Lencioni R, Cioni D, Uliana M, Bartolozzi C. Fatal thrombosis of the portal vein following single-session percutaneous ethanol injection therapy of hepatocellular carcinoma. Abdom Imaging 1998;23:608-610.
19. Ravikumar TS, Buenaventura S, Salem RR, D'Andrea B. Intraoperative ultrasonography of liver: detection of occult liver tumors and treatment by cryosurgery. Can Det Preven 1994; 18:131-138.
20. Curley SA et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
21. Tellez C et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 1998;82:1250-1259.
22. Venook AP. Update on hepatic intra-arterial chemotherapy. Oncology 1997;11:947-970.
23. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1999;88:252-258.
24. Alexander HR et al. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998;16:1479-1489.
25. Kemeny N et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-2048.
26. Bartlett DL, Libutti SK, Alexander HR. Results of isolated hepatic perfusion (IHP) in patients with regionally advanced unresectable colorectal cancer. Proc Soc Surg Oncol 1999;14.
27. Adson MA et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;119:447-651.
28. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal cancer - competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990;16:360-365.
29. Doci R et al. One hundred patients wich hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinanrs. Br J Surg 1991;78:797-801.
30. Rosen CB et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-505.
31. Gayowski TJ et al. Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 1994;116:703-711.
32. Wancbo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg 1996;131:322-329.
33. Elias D et al. Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol 1995;21:510-513.
34. Bines SD et al. Synchronous, metachronous and multiple hepatic resections of liver tumors originating from primary gastric tumors. Surgery 1993;114:799-805.
35. Ravikumar TS et al. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991;126:1520-1524.
36. Onik GM, Atkinson D, Zemel R, Weaver ML. Cryosurgery of liver cancer. Sem Surg Oncol 1993;9:309-317.
37. Zhou XD et al. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. Can Res Clin Oncol 1993;120:100-102.
38. Preketes AP et al. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J Surg 1995;19:768-771.
39. Rossi S et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma: report of 24 patients. Cancer J Sci Am 1995;1:73.
40. Solbiati L et al. Hepatic metastases: percutaneous radio-frequency ablation with cooler-tip electrodes. Radiology 1997;205:367-373.
41. Allgaier HP et al. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999;353:1676-1677.
42. Cuschieri A, Bracken J, Boni L. Initial experience with laparoscopic ultrasound-guided radiofrequency thermal ablation of hepatic tumours. Endoscopy 1999;31:318-321.
43. Curley SA et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:9-11.
44. Therasse E, Briettmayer F, Roche A. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 1993;189:541-547.
45. Lang EK, Brown CL. Colorectal metastases to the liver: selective chemoembolization. Radiology 1993;189:417-422.
46. Trinchet JC, Rached AA, Beugrand M. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261.
47. Feun LG et al. A phase I study of chemoembolization with cisplatin and lipiodol for primary and metastatic liver cancer. Am J Clin Oncol 1994;17:405-410.
48. Perry LJ, Stuart K, Stokes KR, Clouse ME. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 1994;116:1111-1117.
49. Chang AE et al. A prospective randomized trial of regional versus systemic continuous fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-693.
50. Hohn DC et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the northern California oncology group trial. J Clin Oncol 1989;7:1646-1654.
51. Kemeny N et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987;107:459-465.
52. Martin JK et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990;125:1022-1027.
53. Rougier P et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-1118.